Hatch Medical and Phase One Medical Sign Brokerage Agreement

2007 DEC 20 - (NewsRx.com) -- Hatch Medical, L.L.C., a medical device incubator and technology brokerage firm and Phase One Medical, L.L.C., a medical device research and development company announced that they have recently entered into an agreement for Hatch Medical to broker Phase One Medical's patented medical device anchoring technology platforms, Fusion(TM) and Tissue Clip(TM) (see also Thrombosis).
The medical device anchoring platforms utilize shape memory alloy's and proprietary design elements which can be integrated into implantable medical devices improving fixation and security of the implant. Phase One's unique anchoring systems provide bi-directional migration resistance and are not dependant on radial force for fixation unlike hooks and barbs which are used in many implanted devices today. The company anticipates application of the technology to any implantable medical device relying on fixation to prevent migration such as AAA stent grafts, septal defect and PFO repair products and embolic devices.
Phase One Medical is initially utilizing both technology platforms in development of two highly differentiated removable vena cava filter systems for the prevention of Pulmonary Embolism (PE) resulting from Deep Vein Thrombosis (DVT). Both systems are safely and easily deployed using jugular and femoral access, are non-tilting and are easily removed when clinically warranted. Both filters will have the capability to treat large vena cava's in excess of 35mm. For physicians who prefer wire guidance, the Tissue Clip(TM) system will utilize a unique over-the-wire delivery system featuring a .035" centering guidewire.
More than 600,000 people develop Deep Venous Thrombosis (DVT) annually with the most serious complication of DVT being Pulmonary Embolism (PE). PE is the third leading cause of acute cardiovascular death in the U.S. resulting in up to 200,000 deaths each year.